RT Journal Article
SR Electronic
T1 RSV in transplant and immunocompromised patients
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP S34
OP S41
DO 10.3949/ccjm.91.s1.06
VO 91
IS 9 suppl 1
A1 Koval, Christine E.
A1 Gonzalez, Blanca E.
YR 2024
UL http://www.ccjm.org/content/91/9_suppl_1/S34.abstract
AB Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children.